StonvexLoading…
StonvexCore line items from TASK's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $1.18B | $994.99M | $924.37M | $960.49M |
Operating Income | $140.63M | $92.42M | $95.04M | $83.90M |
Net Income | $102.28M | $45.87M | $45.69M | $40.42M |
EPS (Diluted) | $1.10 | $0.50 | $0.48 | $0.39 |
Total Assets | $1.05B | $953.30M | $864.20M | $902.01M |
Total Liabilities | $450.78M | $456.38M | $423.49M | $446.40M |
Cash & Equivalents | $211.68M | $192.17M | $125.78M | $133.99M |
Free Cash Flow OCF − CapEx | $73.72M | $99.78M | $112.67M | $103.34M |
Shares Outstanding | 93.03M | 92.30M | 96.17M | 102.60M |